► Customized research for EDSA vs. PFSCF!
► All in one page research, scroll down. Compare two other stocks.
► Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
Done! Side by Side Research Below for EDSA vs. PFSCF.
↗ Join Our Free Email Newsletter.
► Edesa Biotech Inc. vs. ProMetic Life Sciences Inc.
Industry Match! Industry of Both EDSA and PFSCF:
Health Care/Life Sciences
EDSA
Data Last Updated: 20 hours ago
↻ Update Column 1 to Most Recent
► Key Statistics
Cap: 34M
P/E: N/A
P/S: N/A
Q P/B: N/A
Y Rev: N/A
Q Rev: N/A
Beta: N/A

EDSA Share Stats
► Outstanding Shares
7.14M
► Float Shares
1.54M
► Percent of Float Short
0.81%
EDSA Insider Stats
► Percent Outstanding Insider Ownership
38.5%
► Percent Outstanding Institution Ownership
0.57%
EDSA Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share EDSA Insights
EDSA Profile
► CEO
Dr. Michael Brooks
► Exchange
Nasdaq
► Employees
N/A
► About
Develops pharmaceutical products for treatment of chronic allergic contact dermatitis

EDSA Financials
Annual Financials
Income Statement
► Revenue
N/A
► Net Income
N/A
Cash Flow Statement
► Change in Cash / Investments
N/A
Balance Sheet
► Cash / Investments
N/A
► Short Term Debt
N/A
► Long Term Debt
N/A
► Total Current Assets
N/A
► Total Current Liabilities
N/A
► Total Assets
N/A
► Total Liabilities
N/A
► Stockholder Equity
N/A
Quarterly Financials
Income Statement
► Q Revenue
N/A
► Q Net Income
N/A
Cash Flow Statement
► Q Change in Cash / Investments
N/A
Balance Sheet
► Q Cash / Investments
N/A
► Q Short Term Debt
N/A
► Q Long Term Debt
N/A
► Q Total Current Assets
N/A
► Q Total Current Liabilities
N/A
► Q Total Assets
N/A
► Q Total Liabilities
N/A
► Q Stockholder Equity
N/A

EDSA Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

PFSCF
Data Last Updated: More than 1 mo ago
↻ Update Column 2 to Most Recent
► Key Statistics
Cap: 145.142M
P/E: N/A
P/S: 3.06
Q P/B: 1.03
Y Rev: 47.37M
Q Rev: 8.75M
Beta: 2.23

PFSCF Share Stats
► Outstanding Shares
N/A
► Float Shares
4.65M
► Percent of Float Short
N/A
PFSCF Insider Stats
► Percent Outstanding Insider Ownership
N/A
► Percent Outstanding Institution Ownership
N/A
PFSCF Social Stats
► Followers
0
► B/S Rating Today
0
► B/S Rating All-Time
N/A
Share PFSCF Insights
PFSCF Profile
► CEO
Mr. Kurt Stefan Victor Clulow
► Exchange
OTC
► Employees
487.00
► About
Liminal BioSciences, Inc. is a biopharmaceutical corporation, which engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation and cancer. It operates through the following segments:...

PFSCF Financials
Annual Financials
Income Statement
► Revenue
47.37M
► Net Income
(237.9M)
Cash Flow Statement
► Change in Cash / Investments
(15.78M)
Balance Sheet
► Cash / Investments
7.39M
► Short Term Debt
None
► Long Term Debt
122.59M
► Total Current Assets
40.84M
► Total Current Liabilities
35.73M
► Total Assets
102.89M
► Total Liabilities
166.04M
► Stockholder Equity
(56.6M)
Quarterly Financials
Income Statement
► Q Revenue
8.75M
► Q Net Income
(133.7M)
Cash Flow Statement
► Q Change in Cash / Investments
71.95M
Balance Sheet
► Q Cash / Investments
81M
► Q Short Term Debt
None
► Q Long Term Debt
8.56M
► Q Total Current Assets
108.32M
► Q Total Current Liabilities
26.67M
► Q Total Assets
205.75M
► Q Total Liabilities
71.44M
► Q Stockholder Equity
141.46M

PFSCF Charts
► 10-Year Chart

► 5-Year Chart

► 1-Year Chart

► 6-Month Chart

► 3-Month Chart

► 1-Month Chart

► 1-Day Chart

